J.Safra Asset Management Corp bought a new position in Synopsys, Inc. (NASDAQ:SNPS - Free Report) in the 2nd quarter, according to its most recent filing with the Securities & Exchange Commission. The fund bought 3,056 shares of the semiconductor company's stock, valued at approximately $1,363,000.
A number of other large investors have also added to or reduced their stakes in SNPS. Brighton Jones LLC increased its position in shares of Synopsys by 5.7% during the 4th quarter. Brighton Jones LLC now owns 921 shares of the semiconductor company's stock valued at $447,000 after purchasing an additional 50 shares during the last quarter. Integrated Wealth Concepts LLC lifted its position in Synopsys by 11.6% in the 1st quarter. Integrated Wealth Concepts LLC now owns 760 shares of the semiconductor company's stock worth $326,000 after buying an additional 79 shares during the last quarter. NewEdge Advisors LLC grew its holdings in shares of Synopsys by 15.1% during the 1st quarter. NewEdge Advisors LLC now owns 3,010 shares of the semiconductor company's stock valued at $1,291,000 after purchasing an additional 395 shares during the last quarter. WINTON GROUP Ltd increased its holdings in shares of Synopsys by 9.2% in the second quarter. WINTON GROUP Ltd now owns 758 shares of the semiconductor company's stock worth $389,000 after buying an additional 64 shares during the period. Finally, Treasurer of the State of North Carolina lifted its stake in shares of Synopsys by 2.1% in the 2nd quarter. Treasurer of the State of North Carolina now owns 72,095 shares of the semiconductor company's stock valued at $36,962,000 after acquiring an additional 1,505 shares during the last quarter. Hedge funds and other institutional investors own 85.47% of the company's stock.
Analyst Ratings Changes
Several equities research analysts recently weighed in on the company. Benchmark started coverage on Synopsys in a report on Wednesday, July 15th. They set a "buy" rating and a $570.00 target price for the company. Piper Sandler upgraded Synopsys from a "neutral" rating to an "overweight" rating and boosted their price objective for the company from $450.00 to $550.00 in a research report on Tuesday, June 23rd. Wells Fargo & Company dropped their price objective on Synopsys from $535.00 to $450.00 and set an "equal weight" rating for the company in a research note on Tuesday, August 11th. Citigroup raised their target price on shares of Synopsys from $600.00 to $610.00 and gave the stock a "buy" rating in a report on Thursday, May 28th. Finally, Stifel Nicolaus lifted their target price on shares of Synopsys from $550.00 to $600.00 and gave the stock a "buy" rating in a research note on Thursday, May 28th. Two research analysts have rated the stock with a Strong Buy rating, ten have issued a Buy rating, five have given a Hold rating and one has issued a Sell rating to the stock. According to data from MarketBeat, the stock currently has a consensus rating of "Moderate Buy" and an average target price of $565.06.
Get Our Latest Research Report on Synopsys
Synopsys Stock Performance
SNPS opened at $421.50 on Monday. Synopsys, Inc. has a one year low of $366.00 and a one year high of $626.24. The company has a debt-to-equity ratio of 0.33, a current ratio of 1.43 and a quick ratio of 1.32. The business has a 50 day simple moving average of $425.63 and a two-hundred day simple moving average of $442.93. The firm has a market capitalization of $80.71 billion, a price-to-earnings ratio of 97.57, a PEG ratio of 2.48 and a beta of 1.23.
Synopsys (NASDAQ:SNPS - Get Free Report) last issued its quarterly earnings data on Wednesday, May 27th. The semiconductor company reported $3.35 earnings per share for the quarter, topping analysts' consensus estimates of $3.15 by $0.20. The firm had revenue of $2.28 billion for the quarter, compared to analyst estimates of $2.25 billion. Synopsys had a return on equity of 5.83% and a net margin of 8.91%.The business's quarterly revenue was up 41.9% compared to the same quarter last year. During the same period last year, the company earned $3.67 EPS. Synopsys has set its FY 2026 guidance at 14.720-14.800 EPS and its Q3 2026 guidance at 3.630-3.690 EPS. Analysts predict that Synopsys, Inc. will post 10.65 EPS for the current year.
Key Stories Impacting Synopsys
Here are the key news stories impacting Synopsys this week:
- Positive Sentiment: A discounted-cash-flow analysis suggests Synopsys may be undervalued by approximately 26%, offering potential upside if the company converts strong AI and semiconductor-design demand into sustained cash-flow growth. Synopsys Stock May Be Cheap As Shares Fell 33%
- Positive Sentiment: Analysts and market commentators point to 42% revenue growth, raised guidance and Synopsys’ completed $35 billion acquisition as catalysts that could eventually support a recovery toward substantially higher price levels. These forecasts are speculative and depend on successful integration and continued AI-silicon spending. Prediction: Synopsys Will Hit $650 on This Date
Insiders Place Their Bets
In other news, CEO Sassine Ghazi sold 14,603 shares of the firm's stock in a transaction dated Monday, June 15th. The shares were sold at an average price of $458.96, for a total value of $6,702,192.88. Following the completion of the sale, the chief executive officer directly owned 75,020 shares of the company's stock, valued at approximately $34,431,179.20. This trade represents a 16.29% decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, CFO Shelagh Glaser sold 3,394 shares of Synopsys stock in a transaction dated Friday, June 12th. The shares were sold at an average price of $450.02, for a total transaction of $1,527,367.88. Following the sale, the chief financial officer directly owned 14,358 shares in the company, valued at $6,461,387.16. The trade was a 19.12% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. 0.56% of the stock is currently owned by insiders.
Synopsys Company Profile
(
Free Report)
Synopsys, Inc is a leading provider of electronic design automation (EDA) software and semiconductor intellectual property (IP) used to design, verify and manufacture integrated circuits and complex systems-on-chip (SoCs). Its product portfolio spans tools and technologies for front‑end design and synthesis, simulation and verification, physical implementation and signoff, and design-for-manufacturability, enabling chip designers to move from architecture through tape‑out.
In addition to core EDA offerings, Synopsys supplies a broad set of semiconductor IP building blocks — such as interface, memory and analog/mixed-signal cores — that customers integrate into SoCs to accelerate development.
Further Reading
Want to see what other hedge funds are holding SNPS? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Synopsys, Inc. (NASDAQ:SNPS - Free Report).

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest reporting and unbiased coverage. Please send any questions or comments about this story to contact@marketbeat.com.

Continue following MarketBeat
Add MarketBeat as your preferred source on Google to see our latest stories in your feed.
Before you consider Synopsys, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Synopsys wasn't on the list.
While Synopsys currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we’ll send you MarketBeat’s list of ten stocks set to soar in Summer 2026, despite the threat of tariffs and what's happening in Iran. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.